Resumé
An elderly, fibrillating, diabetic hypertensive patient in heart failure is at risk of stroke from all her cardiovascular morbidities. When such a patient presents with stroke, it is usually difficult to squarely incriminate one. Consequently, precious time is lost while care givers conduct expensive investigations to make a definitive diagnosis. This case report is on one such patient, in whom hypoglycaemia was a plausible cause. Treatment resulted in dramatic recovery. Had neurological complication of drug induced hypoglycaemia not been suspected, the hemiplegia might have become permanent; and any of her risk factors given as a rational explanation. Therefore when a diabetic on treatment presents with stroke, care givers should perform immediate blood glucose test to exclude hypoglycaemia; not withstanding the existence of other risk factors.
Keywords: Treatment induced hypoglycaemia, stroke, multiple risk factors
Résumé
Un vieillard ayant un cœur fibrillant, diabétique et hypertensif souffrant d’un choc cardiaque est a haut risque d’arrêt cardiaque suite à des maladies cardiovasculaires. Lorsqu’un tel patient a un arrêt cardiaque, il est souvent difficile d’identifier la cause exacte. Conséquemment le plupart de temps est utilisé pour des tests afin de faire un diagnostic définitif. Ce rapport est un cas ou l’hyperglycémie était la cause. Le traitement résultait d’une convalescence dramatique. Il avait des complications neurologiques de l’hyperglycémie induite par les médicaments non suspecté. L’hémiplégie pourrait être permanent et n’importe quels facteurs à risque étant une explication rationnelle
Correspondence: Professor Basil N.Okeahialam, Department of Medicine, Jos University Teaching Hospital, Jos, Plateau State, Nigeria. Email: basokeam@yahoo.com
Referencer
Vokonas PS and Kannel WB. Diabetes mellitus and coronary heart disease in the elderly. Clin. Geriatr. Med. 1996; 12(1): 69 – 78.
Adeniyi A, Folsom AR, Branceti FL, Desvorieux M, Pankow JS and Taylor H. Incidence of risk factors for cardiovascular diseases in African Americans. The Atherosclerosis Risk in Community (ARIC) study. J. Natl. Med. Assoc. 2004; 94(12): 1025 – 1031.
Allione A, Quadri R, LoCigno D, Runzo C, Zanone MM and Perri PC. Reversible quadriplegia and non ketotic hyperosmolar coma. Diabetes Care. 2004; 27: 1239 – 1240.
Imam I. Hypoglycaemic hemiparesis in a Nigerian alcoholic. Afr. J. Med. Med. Sci. 2004; 33: 377 – 380.
Onyegbutulem HC and Fasanmade AA. Transient hypoglycaemic hemiparesis. Report of two patients with sulphonylurea treated type 2 Diabetes Mellitus. Niger. Med. Pract. 2006; 50(2): 36 – 38.
Jain H, Beriwal S and Singh S. Alcohol induced ketoacidosis, sever hypoglycaemia and irreversible encephalopathy. Med. Sci. Monit. 2002; 8: CS77 – 79.
Klein F and Ligterink JA. Insulin and cerebral damage. Arch Int. Med. 1940; 65: 1085 – 1096.
Malouf R and Brust JCM. Hypoglycaemia: causes, neurological manifestations and outcome. Ann. Neurol. 1985; 17: 421 – 430.
Berkovic SF, Bladin PF and Darby DG. Metabolic disorders presenting as stroke. Med. J. Austr. 1984; 140(7): 421 – 424.
Amayo EO, Kayima JK and Amayo AA. Transient focal neurological deficits in patients with hypoglycaemia and hyperglycaemia: a report of four cases. E. Afr. Med. J. 1998; 75(1): 53 – 54.
Aronow WS. Risk factors for geriatric stroke. Identification and follow up. Geriatrics. 1990; 45(9): 40, 43 – 44.
Go, AS, Hylek EM, Phillips KS et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285(18): 2370 – 2375.
Hankey GJ. Preventable stroke and stroke prevention. J. Thromb. Haemost. 2005; 3(8): 1638 – 1645.
Khaw AV and Kessler C. Stroke: epidemiology, risk factors and genetics. Haemostaseologie. 2006; 26(4): 287 – 297.
Holstein A, Lankes HG and Egberts EH. Diagnostic pitfalls in sulphonylurea induced neuroglycopaenic syndrome with hemiparesis, dysphasia and somnolence. Med. Klin (Munich). 1998; 93(6): 374 – 377.
English P. Oral agents in the treatment of type 2 diabetes mellitus. Diab Int. 2000; 10(3): 70 -76.
Veitch. PC and Clifton-Bligh RJ. Long acting sulphonylureas – long acting hypoglycaemia. Med. J. Austr. 2004; 180(2): 84 – 85.
Lins PE and Adamson U. Neurological mainfestations of hypoglycaemia. In: B Frier and M Fisher.(Eds). Hypoglycaemia and diabetes: clinical and physiological aspects. Edward Arnold Publishers (A division of Hodder and Stoughton) London. Boston. Melbourne. Auckland. 1993. 347 – 354.
Shintani S, Tsuruoka S and Shiigai T. Hypoglycaemic hemiplegia. A repeat SPECT study. J. Neurol. Neurosurg. Psychiatry.1993; 56(6): 700 – 701.
Portnoy HD. Transient ‘ischaemic’ attacks produced by carotid stenosis and hypoglycaemia. Neurology. 1965; 175: 756 – 769.
Wallis WE, Donaldson I, Scott RS and Wilson J. Hypoglycaemia masquerading as cere- brovascular disease (hypoglycaemic hemiplegia). Ann. Neurol. 1985;18(4): 510 – 512.